• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯喹联合雷帕霉素抑制去分化脂肪肉瘤患者来源的原位异种移植瘤模型的肿瘤生长。

Chloroquine Combined With Rapamycin Arrests Tumor Growth in a Patient-derived Orthotopic Xenograft (PDOX) Mouse Model of Dedifferentiated Liposarcoma.

机构信息

AntiCancer Inc, San Diego, CA, U.S.A.

Graduate School of Medicine, International University of Health and Welfare, Tokyo, Japan.

出版信息

In Vivo. 2022 Nov-Dec;36(6):2630-2637. doi: 10.21873/invivo.12997.

DOI:10.21873/invivo.12997
PMID:36309387
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9677795/
Abstract

BACKGROUND/AIM: Dedifferentiated liposarcoma (DDLS) is a type of soft-tissue sarcoma with a poor prognosis due to distant metastasis and resistance to chemotherapy. The antimalarial drug chloroquine (CQ) can induce apoptosis in cancer cells. CQ in combination with rapamycin (RAPA), an mTOR inhibitor, has shown efficacy on osteosarcoma and other types of cancer. In the present study the efficacy of RAPA combined with CQ on the treatment of a DDLS patient-derived orthotopic xenograft (PDOX) model was investigated.

MATERIALS AND METHODS

A patient-derived DDLS was transplanted into the left retroperitoneum of nude mice to establish a DDLS PDOX nude-mouse model. The mice were randomly divided as follows: untreated control group; CQ group; RAPA group; combined CQ and RAPA group (n=7 for all groups). During the treatment period, tumor volume was measured every 3-4 days with calipers. After 2 weeks treatment, the mice were sacrificed, and H&E staining was performed for histological evaluation. The TUNEL assay was performed to detect apoptosis.

RESULTS

The combination of CQ and RAPA arrested tumor growth in the DDLS PDOX compared to the untreated control (p=0.009) and was significantly more effective than RAPA alone (p=0.009). RAPA alone slowed tumor growth, but the difference was not statistically significant (p>0.05). CQ was not active alone (p>0.05). The number of apoptotic TUNEL-positive cells was significantly higher in the CQ plus RAPA group than in the other groups (p=0.02).

CONCLUSION

Combination therapy with CQ and RAPA arrested tumor growth in a DDLS PDOX model by inducing apoptosis.

摘要

背景/目的:去分化脂肪肉瘤(DDLS)是一种软组织肉瘤,由于远处转移和化疗耐药,预后较差。抗疟药氯喹(CQ)可诱导癌细胞凋亡。CQ 联合雷帕霉素(RAPA),一种 mTOR 抑制剂,已显示出对骨肉瘤和其他类型癌症的疗效。本研究旨在探讨 RAPA 联合 CQ 治疗 DDLS 患者来源的原位异种移植(PDOX)模型的疗效。

材料和方法

将患者来源的 DDLS 移植到裸鼠左腹膜后,建立 DDLS PDOX 裸鼠模型。将小鼠随机分为以下几组:未治疗对照组;CQ 组;RAPA 组;联合 CQ 和 RAPA 组(每组 n=7)。在治疗期间,每隔 3-4 天用卡尺测量肿瘤体积。治疗 2 周后,处死小鼠,进行 H&E 染色进行组织学评价。进行 TUNEL 检测以检测凋亡。

结果

与未治疗对照组相比,CQ 和 RAPA 联合治疗组在 DDLS PDOX 中抑制肿瘤生长(p=0.009),且明显优于 RAPA 单药组(p=0.009)。RAPA 单药组也能减缓肿瘤生长,但差异无统计学意义(p>0.05)。CQ 单药治疗无明显作用(p>0.05)。CQ 联合 RAPA 组的 TUNEL 阳性细胞凋亡数明显高于其他组(p=0.02)。

结论

CQ 和 RAPA 联合治疗通过诱导凋亡抑制 DDLS PDOX 模型中的肿瘤生长。

相似文献

1
Chloroquine Combined With Rapamycin Arrests Tumor Growth in a Patient-derived Orthotopic Xenograft (PDOX) Mouse Model of Dedifferentiated Liposarcoma.氯喹联合雷帕霉素抑制去分化脂肪肉瘤患者来源的原位异种移植瘤模型的肿瘤生长。
In Vivo. 2022 Nov-Dec;36(6):2630-2637. doi: 10.21873/invivo.12997.
2
Targeting Autophagy With the Synergistic Combination of Chloroquine and Rapamycin as a Novel Effective Treatment for Well-differentiated Liposarcoma.靶向自噬联合氯喹和雷帕霉素治疗去分化脂肪肉瘤的研究
Cancer Genomics Proteomics. 2023 Jul-Aug;20(4):317-322. doi: 10.21873/cgp.20384.
3
The combination of gemcitabine and docetaxel arrests a doxorubicin-resistant dedifferentiated liposarcoma in a patient-derived orthotopic xenograft model.吉西他滨和多西他赛的联合应用可使患者来源的原位异种移植模型中的多柔比星耐药去分化脂肪肉瘤停滞。
Biomed Pharmacother. 2019 Sep;117:109093. doi: 10.1016/j.biopha.2019.109093. Epub 2019 Jun 11.
4
Recombinant Methioninase Combined With Tumor-targeting A1-R Induced Regression in a PDOX Mouse Model of Doxorubicin-resistant Dedifferentiated Liposarcoma.重组甲硫氨酸酶联合肿瘤靶向 A1-R 诱导多柔比星耐药去分化脂肪肉瘤 PDOX 小鼠模型的消退。
Anticancer Res. 2020 May;40(5):2515-2523. doi: 10.21873/anticanres.14222.
5
Eribulin Regresses a Doxorubicin-resistant Dedifferentiated Liposarcoma in a Patient-derived Orthotopic Xenograft Mouse Model.依立布林在患者来源的原位异种移植小鼠模型中使多柔比星耐药去分化脂肪肉瘤消退。
Cancer Genomics Proteomics. 2020 Jul-Aug;17(4):351-358. doi: 10.21873/cgp.20194.
6
Oral-recombinant Methioninase in Combination With Rapamycin Eradicates Osteosarcoma of the Breast in a Patient-derived Orthotopic Xenograft Mouse Model.口服重组蛋氨酸酶联合雷帕霉素根除患者来源的原位异种移植小鼠模型中的骨肉瘤。
Anticancer Res. 2022 Nov;42(11):5217-5222. doi: 10.21873/anticanres.16028.
7
Combination of CDK4/6 and mTOR Inhibitors Suppressed Doxorubicin-resistant Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model: A Translatable Strategy for Recalcitrant Disease.CDK4/6 和 mTOR 抑制剂联合抑制患者来源的原位异种移植小鼠模型中的多柔比星耐药骨肉瘤:一种用于难治性疾病的可转化策略。
Anticancer Res. 2021 Jul;41(7):3287-3292. doi: 10.21873/anticanres.15115.
8
Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model.曲贝替定抑制多柔比星耐药的 PDGFRA 激活的脂肪肉瘤患者来源的原位异种移植(PDOX)裸鼠模型。
BMC Cancer. 2018 Aug 20;18(1):840. doi: 10.1186/s12885-018-4703-0.
9
Tumor-targeting Salmonella typhimurium A1-R arrests a doxorubicin-resistant PDGFRA-amplified patient-derived orthotopic xenograft mouse model of pleomorphic liposarcoma.肿瘤靶向鼠伤寒沙门氏菌 A1-R 抑制多形性脂肪肉瘤患者源性原位异种移植鼠模型中耐阿霉素的 PDGFRA 扩增。
J Cell Biochem. 2018 Sep;119(9):7827-7833. doi: 10.1002/jcb.27183. Epub 2018 Jun 22.
10
Metabolic targeting with recombinant methioninase combined with palbociclib regresses a doxorubicin-resistant dedifferentiated liposarcoma.用重组甲硫氨酸酶联合帕博西利进行代谢靶向治疗使多柔比星耐药去分化脂肪肉瘤消退。
Biochem Biophys Res Commun. 2018 Dec 2;506(4):912-917. doi: 10.1016/j.bbrc.2018.10.119. Epub 2018 Nov 2.

引用本文的文献

1
A perspective on patient-derived orthotopic xenograft (PDOX) mouse models for identification of novel and individualized treatment for sarcoma.关于用于肉瘤新型个体化治疗识别的患者来源原位异种移植(PDOX)小鼠模型的观点。
Int J Clin Oncol. 2025 Jun 10. doi: 10.1007/s10147-025-02801-6.
2
The Combination of Tumor-targeting A1-R Plus the Autophagy-inhibitor Chloroquine Synergistically Eradicates HT1080 Fibrosarcoma Cells and .肿瘤靶向A1-R与自噬抑制剂氯喹联合使用可协同根除HT1080纤维肉瘤细胞。
In Vivo. 2025 Jan-Feb;39(1):102-109. doi: 10.21873/invivo.13807.
3
Chloroquine and Chemotherapeutic Compounds in Experimental Cancer Treatment.氯喹和化疗药物在癌症实验治疗中的应用。
Int J Mol Sci. 2024 Jan 12;25(2):945. doi: 10.3390/ijms25020945.
4
Progress in building clinically relevant patient-derived tumor xenograft models for cancer research.用于癌症研究的具有临床相关性的患者来源肿瘤异种移植模型构建进展。
Animal Model Exp Med. 2023 Oct;6(5):381-398. doi: 10.1002/ame2.12349. Epub 2023 Sep 7.
5
Targeting Autophagy With the Synergistic Combination of Chloroquine and Rapamycin as a Novel Effective Treatment for Well-differentiated Liposarcoma.靶向自噬联合氯喹和雷帕霉素治疗去分化脂肪肉瘤的研究
Cancer Genomics Proteomics. 2023 Jul-Aug;20(4):317-322. doi: 10.21873/cgp.20384.
6
Precise and Facile Endotracheal Lung-tumor-implantation Mouse Model Visualized by GFP Expression.通过 GFP 表达可视化的精确、简便的气管内肺肿瘤植入小鼠模型。
In Vivo. 2023 Jul-Aug;37(4):1477-1481. doi: 10.21873/invivo.13231.

本文引用的文献

1
Lysosomal enzyme trafficking factor LYSET enables nutritional usage of extracellular proteins.溶酶体酶运输因子LYSET可实现细胞外蛋白质的营养利用。
Science. 2022 Oct 7;378(6615):eabn5637. doi: 10.1126/science.abn5637.
2
Molecular targeted therapy for advanced or metastatic soft tissue sarcoma.晚期或转移性软组织肉瘤的分子靶向治疗。
Cancer Control. 2021 Jan-Dec;28:10732748211038424. doi: 10.1177/10732748211038424.
3
Combination of CDK4/6 and mTOR Inhibitors Suppressed Doxorubicin-resistant Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model: A Translatable Strategy for Recalcitrant Disease.CDK4/6 和 mTOR 抑制剂联合抑制患者来源的原位异种移植小鼠模型中的多柔比星耐药骨肉瘤:一种用于难治性疾病的可转化策略。
Anticancer Res. 2021 Jul;41(7):3287-3292. doi: 10.21873/anticanres.15115.
4
An mTOR and VEGFR inhibitor combination arrests a doxorubicin resistant lung metastatic osteosarcoma in a PDOX mouse model.mTOR 和 VEGFR 抑制剂联合抑制在 PDOX 小鼠模型中耐阿霉素的肺转移骨肉瘤。
Sci Rep. 2021 Apr 21;11(1):8583. doi: 10.1038/s41598-021-87553-9.
5
Clinical features of multiply recurrent retroperitoneal liposarcoma: A single-center experience.多发性复发性腹膜后脂肪肉瘤的临床特征:单中心经验。
Asian J Surg. 2021 Jan;44(1):380-385. doi: 10.1016/j.asjsur.2020.10.015. Epub 2020 Nov 13.
6
Inhibition of autophagy by chloroquine enhances the antitumor activity of gemcitabine for gallbladder cancer.氯喹抑制自噬增强吉西他滨对胆囊癌的抗肿瘤活性。
Cancer Chemother Pharmacol. 2020 Aug;86(2):221-232. doi: 10.1007/s00280-020-04100-5. Epub 2020 Jul 11.
7
A promising therapeutic combination for metastatic prostate cancer: Chloroquine as autophagy inhibitor and palladium(II) barbiturate complex.氯喹作为自噬抑制剂和钯(II)巴比妥酸盐配合物治疗转移性前列腺癌的一种有前景的联合疗法。
Biochimie. 2020 Aug;175:159-172. doi: 10.1016/j.biochi.2020.05.010. Epub 2020 Jun 1.
8
Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine.成人软组织肉瘤:在个体化医学时代,组织亚型特异性管理的最新进展。
CA Cancer J Clin. 2020 May;70(3):200-229. doi: 10.3322/caac.21605. Epub 2020 Apr 10.
9
Combination of oral recombinant methioninase and decitabine arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma patient-derived orthotopic xenograft mouse model.口服重组甲硫氨酸酶和地西他滨联合治疗耐药性未分化软组织肉瘤患者来源的原位异种移植小鼠模型。
Biochem Biophys Res Commun. 2020 Feb 26;523(1):135-139. doi: 10.1016/j.bbrc.2019.12.024. Epub 2019 Dec 12.
10
The combination of temsirolimus and chloroquine increases radiosensitivity in colorectal cancer cells.特西罗莫司与氯喹联用可提高结直肠癌细胞的放射敏感性。
Oncol Rep. 2019 Jul;42(1):377-385. doi: 10.3892/or.2019.7134. Epub 2019 Apr 23.